Grant: Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Variants
Université Laval
$199,125.00
Development of a rapid and simple test to detect the COVID-19 variants that can be used in remote areas and developing countries.
FY 2021-22
Summary
We have developed a rapid and simple test to detect COVID-19. It uses RNA extracted from a gargle sample. If present, millions of copies of a part of the SARS-Cov-2 are amplified at a fix temperature. Thus the test does not require an expensive temperature cycler normally used for RT-qPCR. The amplified SARS-CoV-2 RNA fragments are specifically cut by the Cas13a RNAse and a crRNA that detects a sequence of 28 nucleotides. Following this specific cut, the Cas13a cuts all the other RNAs present in the sample including a reporter RNA containing a fluorescein molecule on one end and a quencher on the other. When the reporter is intact and the fluorescein molecule is close to the quencher, the latter absorbs the fluorescent signal and the sample stays dark. However, following the cut of the reporter RNA by Cas13a, the positive samples become fluorescent green under a UV light.
The proposed project objective is to modify our current test to detect and differentiate between the SARS-CoV-2 variants (London, South African and Brazilian variants) rapidly (under 2 hours) in remote regions of Canada and in developing countries. The modified test will use two enzymes simultaneously: Cas13, which cuts the RNA including a fluorescent green reporter RNA, and Cas12, which cuts DNA including a fluorescent yellow reporter DNA. The cutting of that reporter DNA leads to fluorescence at a different wavelength. The presence of one the fluorescence signals in two wells will serve to identify which variant is present in the sample. These fluorescent signals will be detected with a smartphone camera and the color combinations will be analyzed in large quantities by a cloud-based server to determine which variants are present and create anonymized reports.
For this project, we have thus established collaborations with clinicians in several countries (Brazil, Maroc, Central African Republic, and Congo). In the future, the test will be modified to detect other viral and bacterial infections.
Department
Program
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Variants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
448988
Name
Tremblay Jacques P
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Variants
Projecttitle
Development of a rapid and simple test to detect the COVID-19 variants that can be used in remote areas and developing countries.
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$199,125
Cihrequipment2
$0
Programname2
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Variants
Keyworddelim
Covid-19; Detection Test; Green Fluorescence; Lamp
Abstract
We have developed a rapid and simple test to detect COVID-19. It uses RNA extracted from a gargle sample. If present, millions of copies of a part of the SARS-Cov-2 are amplified at a fix temperature. Thus the test does not require an expensive temperature cycler normally used for RT-qPCR. The amplified SARS-CoV-2 RNA fragments are specifically cut by the Cas13a RNAse and a crRNA that detects a sequence of 28 nucleotides. Following this specific cut, the Cas13a cuts all the other RNAs present in the sample including a reporter RNA containing a fluorescein molecule on one end and a quencher on the other. When the reporter is intact and the fluorescein molecule is close to the quencher, the latter absorbs the fluorescent signal and the sample stays dark. However, following the cut of the reporter RNA by Cas13a, the positive samples become fluorescent green under a UV light.
The proposed project objective is to modify our current test to detect and differentiate between the SARS-CoV-2 variants (London, South African and Brazilian variants) rapidly (under 2 hours) in remote regions of Canada and in developing countries. The modified test will use two enzymes simultaneously: Cas13, which cuts the RNA including a fluorescent green reporter RNA, and Cas12, which cuts DNA including a fluorescent yellow reporter DNA. The cutting of that reporter DNA leads to fluorescence at a different wavelength. The presence of one the fluorescence signals in two wells will serve to identify which variant is present in the sample. These fluorescent signals will be detected with a smartphone camera and the color combinations will be analyzed in large quantities by a cloud-based server to determine which variants are present and create anonymized reports.
For this project, we have thus established collaborations with clinicians in several countries (Brazil, Maroc, Central African Republic, and Congo). In the future, the test will be modified to detect other viral and bacterial infections.
Competitiondate
202104
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tremblay, Jacques P
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $199,125~ $0~